110
Participants
Start Date
December 15, 2017
Primary Completion Date
September 22, 2019
Study Completion Date
December 19, 2020
Clarithromycin
Clarithromycin two vials of lyophilised powder for reconstitution as solution for IV administration per patient, once daily, for four consecutive days.
Water for injection
Water for injection 20 ml will be administered, diluted in D/W 5%, IV, once daily for four consecutive days
Intensive Care Unit, Saint-Pierre University Hospital, Brussels
Intensive Care Unit, Brugmann University Hospital, Brussels
Intensive Care Unit, Erasme University Hospital, Brussels
Intensive Care Unit, Korgialeneio-Benakeio General Hospital, Athens
Intensive Care Unit, Laikon General Hospital, Athens
2nd Department of Intensive Care Medicine, Attikon University Hospital, Athens
4th Department of Internal Medicine, Attikon University Hospital, Athens
2nd Department of Internal Medicine, Sismanogleio General Hospital, Athens
Intensive Care Unit, Agios Dimitrios General Hospital, Thessaloniki
Intensive Care Unit, G. Gennimatas General Hospital, Thessaloniki
Intensive Care Unit, Theageneio Oncological Hospital, Thessaloniki
Intensive Care Unit, Ippokrateion General Hospital, Thessaloniki
European Commission
OTHER
Hellenic Institute for the Study of Sepsis
OTHER